LinkDoc Technology Limited

Note: LinkDoc Technology Limited withdrew its IPO prospectus in an SEC filing dated April 11, 2022. LinkDoc filed its S-1 (prospectus) on June 14, 2021.  At LinkDoc, our mission is to make precision medicine and personalized care a reality by uncovering the story of every patient journey through the power of data and artificial intelligence. […]

June 15, 2021 Read More

Tremor International Ltd.

(Note: This is NOT a traditional IPO. This is a NASDAQ uplisting from the AIM in London, where the ordinary shares of Tremor International closed on June 11, 2021, at US$22.17 per share. This uplisting is an offering of 6.77 American Depositary Shares (ADS) to trade on the NASDAQ. Each ADS represents two ordinary shares.) […]

Read More

Zimmer Energy Transition Acquisition Corp.

We intend to capitalize on the Zimmer platform to identify, acquire and operate a business in industries that may provide opportunities for attractive risk-adjusted returns in the energy value chain in North America, with a focus on energy transition and sustainability. This includes environmental, social and governance growth-focused companies in the energy, industrial and infrastructure […]

Read More

Rice Acquisition Corp. II

We intend to focus our search for a target business in the broadly defined energy transition or sustainability arena. Specifically, although we may pursue an acquisition opportunity in any business industry or sector, we plan to concentrate our search on supply-side solutions and innovations that enable the economy to decarbonize in sectors that include renewable fuels, […]

Read More

Bright Health Group

Bright Health was founded in 2015 to transform healthcare. Our mission of Making Healthcare Right. Together. is built upon the belief that by connecting and aligning the best local resources in healthcare delivery with the financing of care, we can drive a superior consumer experience, reduce systemic waste, lower costs, and optimize clinical outcomes. We believe that […]

Read More

Alzamend Neuro

We are a preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. With our two current and future product candidates, we aim to bring treatments or cures to market at a reasonable cost as quickly as possible. Far too many individuals — patients and caregivers — suffer from the burden […]

Read More

DILA Capital Acquisition

We are a blank check company formed under the laws of the State of Delaware on Dec. 30, 2020. We intend to focus our search on companies with significant operating technological advantages that are headquartered in Latin America, as well as businesses located in the United States that cater to the Hispanic community.  (Note: DILA Capital […]

Read More

G Squared Ascend II

G Squared Ascend II Inc. is a blank check company incorporated as a Cayman Islands exempted company. This is the second blank check company created by Larry Aschebrook, the founder and managing partner of G Squared, a venture fund focused on the tech sector, along with Ward Davis, a principal at G Squared, and Tom […]

June 14, 2021 Read More

Femasys Inc.

We are a biomedical company focused on transforming women’s healthcare by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. Our mission is to provide women worldwide with superior minimally-invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. As a woman-founded and led […]

Read More

Sprinklr, Inc.

Sprinklr empowers the world’s largest and most loved brands to make their customers happier. We do this with a new category of enterprise software – Unified Customer Experience Management, or Unified-CXM – that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, communicate across digital channels, […]

Read More